Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 31.86 |
Low | 31.86 |
Bid | -- |
Offer | -- |
Previous close | 31.86 |
Average volume | -- |
---|---|
Shares outstanding | 57.03m |
Free float | 38.57m |
P/E (TTM) | 15.73 |
Market cap | 1.90bn USD |
EPS (TTM) | 2.11 USD |
Data delayed at least 15 minutes, as of Sep 28 2023 07:08 BST.
More ▼
- Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
- Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
- Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates